VOLUME 1 - NUMBER 1 - 2019

The LH/AMH ratio as a predictive value for the outcome of assisted reproductive techniques


  • Julian Marschalek, Kazem Nouri, Franz Xaver Singhartinger, Marlene Hager, Marie-Louise Marschalek, Katharina Walch, Johannes Ott
  • Original articles, 43-47
  • Full text PDF
  • Purpose: This study was conducted to test the luteinizing hormone/anti-Müllerian hormone (LH/AMH) ratio as a possible new predictive factor for outcomes after controlled ovarian hyperstimulation (COH) in women undergoing in vitro fertilization (IVF) / intracytoplasmic sperm injection (ICSI) treatment. || Methods: This retrospective cohort study included 164 women submitted to their first IVF/ICSI treatment. || Results: Pregnancy and live birth rates were 21.5% and 18.6%, respectively. In a generalized linear model for the prediction of oocyte quantity after COH, age (odds ratio, OR, 0.98, 95% confidence interval, CI, 0.97;0.99), smoking (OR 0.83, 95%CI 0.68;0.99), AMH serum levels (OR 1.06, 95%CI 1.03;1.09) and a higher LH/AMH ratio (OR 0.97, 95%CI 0.96;0.98) were associated with oocyte quantity. For both ongoing pregnancy and live birth rates, only age was found to be predictive (OR 0.92, 95%CI 0.86;0.97, and 0.87, 95%CI 0.78;0.96; respectively). || Conclusion: The LH/AMH ratio is a new predictive parameter for oocyte quantity after COH. However, for the clinically more relevant outcome parameters of ongoing pregnancy and live birth, only patient age was significantly predictive.

  • KEY WORDS: Ovarian reserve test, anti-Müllerian hormone, luteinizing hormone, follicle-stimulating hormone, IVF, ICSI, outcome, pregnancy rate, live birth.